@ZinselmeyerB Avatar @ZinselmeyerB Bernd H Zinselmeyer

Bernd H Zinselmeyer posts on X about $sgmo, $qure, in the, $pfe the most. They currently have [-----] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

Engagements: [-----] #

Engagements Line Chart

Mentions: [--] #

Mentions Line Chart

Followers: [-----] #

Followers Line Chart

CreatorRank: [-------] #

CreatorRank Line Chart

Social Influence

Social category influence finance 19% stocks 12% countries 2% travel destinations 2% currencies 2% exchanges 1% technology brands 1% cryptocurrencies 1%

Social topic influence $sgmo #1, $qure 5%, in the 4%, $pfe 4%, $ntla 4%, $sgmos 3%, bp 3%, #bp 3%, science 3%, $tak 3%

Top accounts mentioned or mentioned by @sangamotx @biotechanalysst @mitchellreed09 @geneinvesting @soerenberlin @bambossie81 @809trader @francaole @yusufhameed @tradernorway @coronanlyme @mehtamanal @rjalagam9111 @adamfeuerstein @auditor112017 @rnaianalyst @sandymacrae23 @officialcantor @cantorfitzgerld @astellasus

Top assets mentioned uniQure N.V. (QURE) Pfizer, Inc. (PFE) Intellia Therapeutics, Inc (NTLA) Eli Lilly and Company (LLY) AstraZeneca PLC (AZN) Denali Therapeutics Inc. Common Stock (DNLI) Neurocrine Biosciences, Inc. (NBIX) Catalyst Pharmaceutical Inc. (CPRX) Novo-Nordisk (NVO) Synthetify (SNY) Metsera, Inc. (MTSR) Vertex Protocol (VRTX) Bristol-Myers Squibb Co (BMY) Wave Life Sciences Ltd. Ordinary Shares (WVE) Metagenomi Technologies, LLC (MGX) BioMarin Pharmaceutical, Inc. (BMRN) Amicus Therapeutics, Inc (FOLD)

Top Social Posts

Top posts by engagements in the last [--] hours

"@BiotechAnalysst Not a rating note but @Official_Cantor s BBB report gives $SGMO outsized attention as a validated BBB-crossing AAV platform placed alongside CNS delivery leaders like $VYGR $DNLI and $NBIX. That kind of positioning is rarely accidental. @SangamoTx @cantorfitzgerld"
X Link 2025-12-13T15:47Z [----] followers, [----] engagements

"@mehtamanal @appalachiangabe $SGMO #Fabry is manufactured via a #CMO - and the 1-year stability #CMC data in the #BLA are manufacturer/site-specific Bottom line: you dont just move Fabry manufacturing to an @AstellasUS plant over night. A site transfer triggers major CMC work and 18+ MONTHS of DELAY"
X Link 2026-01-17T14:38Z [----] followers, [----] engagements

"@auditor112017 @Jota5571189851 @MethOSilly @MitchellReed09 @Franca_ole @Blake92399 From my perspective $SGMO are already running a very full slate of programmes. Before venturing into #HepB - where the field is already rather crowded - it would seem more prudent to refocus on their #Treg platform once the cash position comfortably allows"
X Link 2026-02-01T02:16Z [----] followers, [----] engagements

"@BAMBossie81 @SangamoTx $SGMO Why is this #Investor so keen to stay anonymous Why the #Warrants What are the reporting rules - wouldnt a Schedule [--] filing be required Any plausible theories"
X Link 2026-02-03T22:58Z [----] followers, [---] engagements

"@RNAiAnalyst Perhaps its best not to show @GeneInvesting that Dirk considers $SGMO s #Fabry gene therapy superior to $QURE s GT. Some contradictions require careful digestion"
X Link 2026-02-06T14:40Z [----] followers, [---] engagements

"@Prof_Dollar Dear valued colleague @Prof_Dollar: $QURE PR = -Gal A over a year (ONE patient). $SGMO = patients followed ovber [--] years. One-year anecdotes are charming; theyre not a dataset https://finance.yahoo.com/news/uniqure-announces-updated-preliminary-amt-120500052.html https://finance.yahoo.com/news/uniqure-announces-updated-preliminary-amt-120500052.html"
X Link 2026-02-06T16:04Z [----] followers, [---] engagements

"@Prof_Dollar Im just comparing $QURE #Fabry with $SGMO Fabry here - not platforms or anything else. Im concerned youre drawing conclusions this (FABRY) dataset cant support yet. Time will tell as the data matures. See also: https://x.com/RNAiAnalyst/status/2019755718258102399 $qure AAV Fabry gene therapy does not sound as promising as $sgmo's with variability in transgene expression and dose-limiting liver enzymes. Preliminary take pending full presentation today. https://t.co/DgdciVjMNO https://x.com/RNAiAnalyst/status/2019755718258102399 $qure AAV Fabry gene therapy does not sound as"
X Link 2026-02-06T16:37Z [----] followers, [---] engagements

"@TraderNorway Please compare todays $QURE #Fabry data with $SGMO - might be worth watching the [--] min video attached below: https://x.com/ZinselmeyerB/status/2017156525274333689 Revisiting @SangamoTx last years ST-920 #Fabry gene therapy material - a deliberate warm-up ahead of new updates at [----] WorldSymposium next week. Feels increasingly launch-adjacent. $SGMO https://t.co/l9v6oTqkcB https://x.com/ZinselmeyerB/status/2017156525274333689 Revisiting @SangamoTx last years ST-920 #Fabry gene therapy material - a deliberate warm-up ahead of new updates at [----] WorldSymposium next week. Feels"
X Link 2026-02-06T20:59Z [----] followers, [----] engagements

"@TraderNorway they got that letter [--] times in the last [--] years"
X Link 2026-02-06T21:05Z [----] followers, [---] engagements

"@TraderNorway By the way: Im long $QURE for the Huntingtons program and long $SGMO for #Fabry and the zinc-finger platform #ZiFi https://x.com/ZinselmeyerB/status/2019883664457494931 @TraderNorway Cash is the real risk for $SGMO. The $1 bid deficiency is ALWAYS extendable. #Nasdaq looks at sustained low price and weak daily trading volume. With over $1M/day+ in daily dollar volume (often $3M/day) SGMO isnt a delisting priority. @NasdaqExchange https://t.co/36Yt3NQ1Bh https://x.com/ZinselmeyerB/status/2019883664457494931 @TraderNorway Cash is the real risk for $SGMO. The $1 bid deficiency is"
X Link 2026-02-06T21:27Z [----] followers, [----] engagements

"@MitchellReed09 For #Fabry $SGMO should avoid #BP (IMO) and consider a self-launch. IF partnering think rare-disease specialty pharma like Catalyst: $CPRX in-licenses late-stage assets and commercialises . https://catalystpharma.com/about-catalyst/utm_source=chatgpt.com https://catalystpharma.com/about-catalyst/utm_source=chatgpt.com"
X Link 2026-02-07T17:28Z [----] followers, [---] engagements

"@GothamGirl_1 Im not sure mgmt fully realise how far along #Fabry is. At this stage it doesnt need a #BP partner; it needs a focused (in-house) launch. $SGMO science is 1st-rate - yet on #BD/fin one sometimes wonders who brought the calculator. https://x.com/ZinselmeyerB/status/2019120198977012168s=20 @JanvDes @kikiruncha NO #Fabry $SGMO @SangamoTx : Commercialise it in house. After approval the cost base is much lower than the market thinks - no need for a huge commercial footprint. https://t.co/svCOM0RJz5 https://t.co/PSA9qZYOiE https://x.com/ZinselmeyerB/status/2019120198977012168s=20"
X Link 2026-02-08T09:25Z [----] followers, [---] engagements

"@GothamGirl_1 $SGMO #Fabry gene therapy ST-920 (isaralgagene civaparvovec) is produced via a #CMO/#CDMO - most likely Thermo Fisher (Patheon Pharma Services). Therefore manufacturing (small to larg) is already addressed in the CMC workstream of the #BLA"
X Link 2026-02-08T09:48Z [----] followers, [---] engagements

"@JaxSmith48060 @GothamGirl_1 $SGMO ST-503 (#Pain) is in an early clinical stage and therefore ideal for #BP partnering in contrast to #Fabry which is a finished drug. Delisting see this conversation: https://x.com/i/status/2019943541053747445 @TristatePhil @TraderNorway @NasdaqExchange thats what i found on ChatGPT . https://t.co/2z7HqHobos https://x.com/i/status/2019943541053747445 @TristatePhil @TraderNorway @NasdaqExchange thats what i found on ChatGPT . https://t.co/2z7HqHobos"
X Link 2026-02-08T18:40Z [----] followers, [---] engagements

"@GeneInvesting @BAMBossie81 Thanks I thought you were confusing it with migalastat (Galafold) which some refer to as the #Fabry pill and which only works in specific amenable GLA variants (meaning the mutant enzyme can be stabilised and regain function). Whereas $SGMO ST-920 works for ALL variants"
X Link 2026-02-09T18:06Z [----] followers, [---] engagements

"@yusufhameed @BiotechAnalysst @HCWCO @SangamoTx The #Fabry physicians I spoke with after the meeting said the cardiac data are genuinely novel - and they havent seen comparable results reported with any other therapy. If that holds $SGMO looks best-in-class"
X Link 2026-02-10T15:31Z [----] followers, [---] engagements

"@DarrenEstes SURE - but that does NOT require a Big Pharma (#BP) partner. Big Pharma is mainly useful for clinical trials and manufacturing and those are already done/covered. Upfront $$$ can also be achieved with a specialist pharma or a VC-style partner"
X Link 2026-02-10T17:45Z [----] followers, [---] engagements

"@Corona_N_Lyme @BiotechAnalysst Who owe $SGMO how many $ for what"
X Link 2026-02-13T21:03Z [----] followers, [---] engagements

"@SangamoTx questions after today: ST-503 (#Pain): funded to execute Phase [--] STAC-BBB/#Prion: starting human study this summer #Fabry: can we run without a partner Ownership: are we looking at a shareholder base reshuffle - new major holders coming in $SGMO"
X Link 2026-02-03T17:27Z [----] followers, [----] engagements

"@rjalagam9111 @MitchellReed09 NO: Commercialize Fabry together with a VC partner: The VC funds the launch The VC gets partial ownership/economic rights in the Fabry asset only No new corporate shares No dilution at the parent level"
X Link 2026-02-07T17:57Z [----] followers, [---] engagements

"@BAMBossie81 @SangamoTx If anyone still believes Big Pharma loves gene therapy per se just look at the tape: $NVO and $TAK are shutting down gene therapy operations. $PFE and $SNY walked away from $SGMO programs "
X Link 2026-02-12T13:20Z [----] followers, [---] engagements

"RT @McFaul: Why do we need a nuclear deal with Iran when Trump told us several months ago that we obliterated their nuclear program with ou"
X Link 2026-02-15T04:23Z [----] followers, [----] engagements

"@Fitzdad55 @ErayArc1846032 @julienprouvost2 @PeterWardJD @Soeren_Berlin Only clinical Most biotech assets die before first patient dosing. $SGMO Fabry gene therapy ST-920 has completed clinical development and is now in registration: Thats not early stage - thats regulatory stage"
X Link 2026-02-15T17:37Z [----] followers, [---] engagements

"@PeterWardJD @Soeren_Berlin $SGMO reverse split panic is overdone. If its simply a compliance move and the revenue/strategy path is clear (THAT IS THE CRUX); its cosmetics; not fundamentals. [--] $0.40 [--] $4.00. Same pie just sliced differently"
X Link 2026-02-14T16:34Z [----] followers, [----] engagements

"@MitchellReed09 @Fitzdad55 @ErayArc1846032 @julienprouvost2 @PeterWardJD @Soeren_Berlin Still impressed by the science and the pace of $SGMO s #Fabry & #Pain progress. Whats almost unheard of: how far theyve pushed Fabry without ANY Big Pharma support. Yes Im aware of the communication and financing mess"
X Link 2026-02-16T03:42Z [----] followers, [---] engagements

"@BAMBossie81 @809trader strategic partnership / co-development agreements do happen. Something fairly recent: https://news.bms.com/news/details/2025/Bristol-Myers-Squibb-and-Bain-Capital-Create-New-Company-Dedicated-to-Developing-Innovative-Immunology-Therapies-that-Address-the-Unmet-Medical-Needs-of-Patients/default.aspx https://news.bms.com/news/details/2025/Bristol-Myers-Squibb-and-Bain-Capital-Create-New-Company-Dedicated-to-Developing-Innovative-Immunology-Therapies-that-Address-the-Unmet-Medical-Needs-of-Patients/default.aspx"
X Link 2025-09-14T22:39Z [---] followers, [--] engagements

"@BAMBossie81 @809trader Lets stick to the facts: theyre running out of cash in weeks. Yet theyve hired senior staff who wouldnt have joined without a longer-term plan. Clearly a strategy is been in the pipeline for months to secure funds and move products forward"
X Link 2025-09-14T23:11Z [---] followers, [--] engagements

"@BAMBossie81 @809trader Absolutely agree Not mentioned the stock price here. Just said #Fabry #Gene #therapy and other #assets will move forward and $SGMO is far from #bankrupt - despite the doomsayers. That said with commercialization ahead I believe the stock will rise sooner or later"
X Link 2025-09-14T23:28Z [---] followers, [---] engagements

"@doepke_michel Good for $MTSR $PFE being @pfizer will as ever contrive to torch shareholder value with this acquisition its practically a house tradition. https://x.com/ZinselmeyerB/status/1911758149171675152t=WXYTPdcTrlqhCFBtFp5EIw&s=19 @Longroaderstar @pfizer $PFE Pfizer has lost nearly half its value since the pandemic despite spending $70B on acquisitions like Seagen. Why shareholders haven't long since ousted this grossly incompetent money-burning management is beyond me. https://t.co/k4fqAMqBl6 https://t.co/uaWoJMAyHs"
X Link 2025-09-22T14:24Z [---] followers, [---] engagements

"@Soeren_Berlin @GeneInvesting One might almost cynically jest that @adamfeuerstein and @GeneInvesting have now made it their lifes mission to program bots spreading misinformation about $SGMO - precisely because their real selves no longer carry any weight"
X Link 2025-09-24T20:39Z [---] followers, [---] engagements

"@meangenebio @BAMBossie81 @Franca_ole After receiving the notice they have [---] days to resolve the issue after which they may apply for an additional 180-day extension. Cash is indeed a concern for $SGMO but this delisting threat is nothing more than a storm in a teacup"
X Link 2025-09-28T22:13Z [---] followers, [---] engagements

"@Longroaderstar $SGMO - Does anyone actually know something or is this just the usual pre-market background noise"
X Link 2025-09-30T09:23Z [---] followers, [----] engagements

"@wintament Its already been announced (more than once) that recruiting will start in Q4 [----]. If a press release once the first pair or group has been dosed"
X Link 2025-10-14T19:51Z [---] followers, [---] engagements

"@somerussell @appalachiangabe @IsakAleksander $SGMO Progress is happening: the pipelines moving forward clinical recruitment for the #Pain GT trial has begun preparation for #Fabry #BLA continues and they seem confident enough to meet payroll by end-Oct - otherwise wed have seen a PR by now right"
X Link 2025-10-17T13:16Z [---] followers, [----] engagements

"@UnionSteel2017 An $SGMO earnings call before market open 5:30 a.m. in San Francisco. Analysts have to read the release before that. That timing is highly unusual its never been like this before with @SangamoTx News from Europe or Asia in the night before"
X Link 2025-10-30T20:10Z [----] followers, [----] engagements

"@smargach @MartinLopezNov1 @JustTradingHoy Fair but by listening to $SGMO recent presentations they are not ruling out Partnering for #Fabry and in fact suggested partnering for $SCD in the near future. Additionally #Hemophila collab. with $PFE can generate up to 240M millstones (next [--] Month) + long-lasting royalties"
X Link 2023-03-08T18:43Z [---] followers, [---] engagements

"@MitchellReed09 @DHogweed @BiotechAnalysst @f_fauser @RNAiAnalyst I agree but hours ago people on here were even criticizing SM and $SGMO sending people to the conference cause the Hotels Airfare and drinks for the scientists were too expensive LOL https://x.com/RNAiAnalyst/status/1787786959257063776 https://x.com/RNAiAnalyst/status/1787786959257063776"
X Link 2024-05-09T15:39Z [---] followers, [---] engagements

"@iPellarini @SangamoTx $SGMO #Treg #CARTreg #Kidney #Transplantation https://www.theglobeandmail.com/investing/markets/markets-news/GetNews/27142631/kidney-transplant-rejection-pipeline-forecast-2024-fda-approvals-therapies-and-leading-companies-by-delveinsight-veloxis-pharma-eledon-pharma-sangamo-horizon-therapeutics-csl-behring-medeor/"
X Link 2024-07-02T13:58Z [----] followers, [---] engagements

"The clerical abusers use every opportunity to distract from their misdeeds The picture that served as a template for the so-called "trans buffet" that everyone is upset about is NOT the "Last Supper" but a scene from Olympus. Olympus. Olympic Games https://musee-magnin.fr/collection/objet/le-festin-des-dieux Friends my thoughts on the opening ceremony of the Paris Olympics. #Olimpiadas2024 #OlympicGames https://t.co/xU1ljFMZft https://musee-magnin.fr/collection/objet/le-festin-des-dieux Friends my thoughts on the opening ceremony of the Paris Olympics. #Olimpiadas2024 #OlympicGames"
X Link 2024-07-29T14:01Z [---] followers, [---] engagements

"@GeneInvesting Good morning based on $NTLA performance you might need to save some cash on coffee. In order to increase your pulse without coffee I sent you a [--] Month $SGMO / $NTLA comparison. That should do the Trick ;-)"
X Link 2024-10-08T14:11Z [----] followers, [----] engagements

"@RoyWessex @UnionSteel2017 As soon the deal is inked it is a press release"
X Link 2025-02-26T12:33Z [---] followers, [---] engagements

"@mehtamanal I see $VRTX as a potential buyer/Partner of $SGMO HemA GT"
X Link 2025-03-12T17:40Z [---] followers, [---] engagements

"@Soeren_Berlin If VCs truly understand Sangamo and its science/programs there's another angle: a hostile takeover. Several of $SGMOs assets could stand alone as independent companies; just look at what @bmsnews and @BainCapital did yesterday. $BMY @SangamoTx https://x.com/PearlF/status/1950031572893040652t=8ZgdHORC3s5aUodV0zn-8Q&s=19 https://x.com/PearlF/status/1950031572893040652t=8ZgdHORC3s5aUodV0zn-8Q&s=19"
X Link 2025-07-30T13:03Z [---] followers, [----] engagements

"@Ralf2314 @BiotechAnalysst @AstellasUS could snap up @SangamoTx MINT platform at any time - but it's preclinical and the real money is always in the clinic: we will see $$$ when $LLY $RHHBY & $ALPMY file IND for $SGMO STAC_BBB after the capsid proves tolerability in humans (#prion) around end-next year"
X Link 2025-07-30T13:20Z [---] followers, [---] engagements

"@MaxPowerNGS @Franca_ole @JamieSoftware I dont agree. Each of these deals is lengthy and complex. If someone wants more than one of $SGMO s assets they should seriously consider a #buyout of the whole company. #BO"
X Link 2025-08-18T19:47Z [---] followers, [---] engagements

"@auditor112017 After @uniQure_NVs success yesterday showing 75% slowdown of #Huntingtons with gene therapy the future looks like one-and-done - vs. @WaveLifeScis repeated #ASO injections. Dont forget @TakedaPharma still has a GT collaboration with @SangamoTx. $WVE $SGMO $TAK"
X Link 2025-09-25T15:34Z [---] followers, [----] engagements

"@cactustuoi @jawnzilla @Soeren_Berlin @Franca_ole Missing from the list of companies they cover - though Im quite sure they do cover $SGMO as I distinctly remember them recently reaffirming their $10 price target. Please check if HCW is covering $MGX and $NTLA https://x.com/BiotechAnalysst/status/1963988595921842271t=wjmYwQHoi0iV5F-nOhZhwQ&s=19 HCW $SGMO PT $10 .Accelerated Approval of BLA which Sangamo plans to submit in 1Q26. We believe the full dataset further derisks isa-vec as a onetime #durable treatment with #multiorgan benefit and a favorable #safety profile; we reiterate our Buy"
X Link 2025-10-12T18:31Z [---] followers, [----] engagements

"@Reg0sce https://www.hsfkramer.com/en_US/insights/2025-09/potential-cfius-impacts-of-us-government-shutdown https://www.hsfkramer.com/en_US/insights/2025-09/potential-cfius-impacts-of-us-government-shutdown"
X Link 2025-10-23T15:37Z [---] followers, [----] engagements

"@bduclaux A #buyout shows deep commitment to a company you want to grow. Its not a one-night stand. In this scenario a quiet loan would naturally be provided to keep projects going - its just normal business"
X Link 2025-10-23T18:13Z [---] followers, [---] engagements

"@GeneInvesting Based on these two lines thats a fair hypothesis - Ill give you that. However youve said quite a few other things especially about Zinc Fingers #ZiFi that make it rather difficult to confirm your statement globally"
X Link 2025-10-25T18:13Z [---] followers, [---] engagements

"@MichaelMaiello @_OliverVenture Just a note: this cheerful 80-year-old playing cards and all has made it this far without any $NTLA #CRISPR intervention. So maybe the risk-to-benefit ratio isnt quite as stellar as you and @GeneInvesting like to sell it What you think @adamfeuerstein"
X Link 2025-10-27T18:56Z [---] followers, [----] engagements

"@MichaelMaiello @adamfeuerstein @_OliverVenture @GeneInvesting I absolutely agree - and at the end of the trial well evaluate. As simple as that. $NTLA is acting very responsibly; theyll most likely resume when appropriate. Thats all Im saying"
X Link 2025-10-27T20:07Z [---] followers, [---] engagements

"@Corona_N_Lyme @BiotechAnalysst @yusufhameed @CathieDWood Then Id strongly encourage @CathieDWood to initiate a fresh round of DD on #ZiFi and @SangamoTx $SGMO . Her team might start by taking a closer look at @nchromabio - their #epigenetic GT approach using ZiFis their founders and their investors https://x.com/ZinselmeyerB/status/1969039501713383535t=DejPwS1xaxawhE4t7HUNsw&s=19 At this #ESGCT25 were seeing the whos who and plenty of premium science from @nchromabio & @SangamoTx - especially #epigenetic gene therapy approaches mediated by Zinc Finger Proteins #ZFP. @nchromabio admires $SGMO"
X Link 2025-10-28T12:28Z [---] followers, [---] engagements

"@Corona_N_Lyme @BiotechAnalysst @yusufhameed @CathieDWood @SangamoTx @nchromabio Dear @CathieDWood here are a few leads that might be worth a peek for your next due diligence on Zinc Finger Proteins - #ZFP #ZiFi @SangamoTx $SGMO and @nchromabio with their #epigenetic approach. https://www.nchromabio.com/ https://www.nchromabio.com/"
X Link 2025-10-28T12:41Z [---] followers, [----] engagements

"@JamieSoftware @JoshInvestValue To my knowledge there are very few if ANY capsids that have been validated for CNS delivery in humans. Please let me know if you are aware of any such examples"
X Link 2025-10-28T22:00Z [---] followers, [--] engagements

"$AZN will host webcast for investors and analysts on Nov [--] at 13:00 GMT 13:00 GMT (London) is 9:00am ET (New York). $SGMO will hold a conference call at 8:30 a.m. ET on Thursday November [--] both call will overlap Im not suggesting anything - merely making an observation. @UnionSteel2017 An $SGMO earnings call before market open 5:30 a.m. in San Francisco. Analysts have to read the release before that. That timing is highly unusual its never been like this before with @SangamoTx News from Europe or Asia in the night before https://t.co/7QpKfKIEjx @UnionSteel2017 An $SGMO earnings call before"
X Link 2025-10-31T16:18Z [----] followers, [----] engagements

"https://www.astrazeneca.com/investor-relations/9m-and-q3-2025-results-event.html https://www.astrazeneca.com/investor-relations/9m-and-q3-2025-results-event.html"
X Link 2025-10-31T16:19Z [---] followers, [---] engagements

"@Soeren_Berlin CURIOUS Is the mouse really curious when it looks into the cobras eyes - or just making peace with its investment choices $SGMO earnings call"
X Link 2025-11-03T23:59Z [---] followers, [----] engagements

"@MitchellReed09 Quick thought: filing a Schedule 13D or 13G doesnt necessarily mean a takeover is happening. But if someone is accumulating stock for a buyout you'd normally see those filings. So if thats the case why arent we seeing them Just a little something to mull over "
X Link 2025-11-12T18:48Z [---] followers, [---] engagements

"@auditor112017 @BiotechAnalysst @SangamoTx CEO Sandy Macrae M.B. Ch.B. Ph.D. spent over four years as Global Medical Officer at @TakedaPharma It would surprise no one if hes already nudging the right people at $TAK. $SGMO"
X Link 2025-11-15T16:49Z [----] followers, [---] engagements

"@rjalagam9111 @BiotechAnalysst University of Washington in Seattle WA used $SGMO #ZiFi Please don't confuse with Washington University (WashU in St. Louis MO) @WashU"
X Link 2025-11-15T17:25Z [---] followers, [---] engagements

"@rjalagam9111 They used AAV vector pAAV-6P-SWB. That means in principle most CNS-tropic vector should work - including the standard AAV9 $SGMO is using in the pain study RIGHT NOW (Intrathecal administration) and in the future potentially even STAC-BBB for IV delivery"
X Link 2025-11-16T16:58Z [---] followers, [----] engagements

"@809trader That suggestion is essentially suicide born of the fear of a merely potential death. $SGMO"
X Link 2025-11-21T13:41Z [---] followers, [---] engagements

"Neuro-Immunology absolutely rocks - not only here at #AIC2025 in #Chicago but also back home at @washumedicine in St. Louis. @WashU #WashU #WashUMed #WUSTL #Immunology #Neuroscience #NeuroImmunology Sunday morning at #AIC2025 is all about neuroimmunology https://t.co/7KFBEvMkZL Sunday morning at #AIC2025 is all about neuroimmunology https://t.co/7KFBEvMkZL"
X Link 2025-11-23T15:44Z [----] followers, [---] engagements

"@DarrenEstes With BP perhaps - however for securing cash for example through loans translational financing deals or venture-pharma development partnerships this is an enormous step in de-risking. $SGMO https://x.com/ZinselmeyerB/status/1991861352273719638t=eSE0JsPZI5mj-0crkj43Mw&s=19 @adamfeuerstein Wouldnt you say that $SGMO pressing on with low funds is still far better than coming to a standstill - especially for #Fabry patients and even when it comes to securing cash for example through loans / translational financing deals / venture-pharma development partnerships"
X Link 2025-11-24T17:24Z [----] followers, [----] engagements

"@Maasta1234 @ShortSeller Dear @ShortSeller ; I disagree with your $SGMO thesis - and thats totally fine But if youre so convinced put your money where your mouth is Funny enough even shorts seem to get cold feet: the short position is shrinking despite higher share count. https://x.com/BiotechAnalysst/status/1993671729412211101t=MEGt5dyPFEd7xndVo2kF8A&s=19 $SGMO another 2.5M shorts covered https://t.co/7xEDoPd4yE https://x.com/BiotechAnalysst/status/1993671729412211101t=MEGt5dyPFEd7xndVo2kF8A&s=19 $SGMO another 2.5M shorts covered https://t.co/7xEDoPd4yE"
X Link 2025-11-26T16:09Z [----] followers, 12.4K engagements

"@CzinegeErvin @Daractenus FYI: Catherine the Great: Was born as Sophie Friederike Auguste von Anhalt-Zerbst Birthplace: Stettin Kingdom of Prussia (today Szczecin Poland) Native language: German She only learned Russian later after being brought to Russia to marry the future Emperor Peter III"
X Link 2025-11-30T20:02Z [----] followers, [--] engagements

"@kaysaaa81 @BiotechAnalysst Indeed something like this would be nice and its quite realistic for three of $SGMO s programs: #Fabry #Pain #HemA https://x.com/mehtamanal/status/1996563267234525379 Interesting model for $SGMO ST-920 @sandymacrae23 👇 https://t.co/vfqMZIyq1z https://x.com/mehtamanal/status/1996563267234525379 Interesting model for $SGMO ST-920 @sandymacrae23 👇 https://t.co/vfqMZIyq1z"
X Link 2025-12-04T20:46Z [---] followers, [---] engagements

"@MitchellReed09 @ValueForAll1 @Official_Cantor @cantorfitzgerld @SangamoTx Non-dilutive cash/$$$"
X Link 2025-12-15T20:16Z [----] followers, [--] engagements

"@GeneInvesting One cant help wondering whether the $BMRN management has absorbed too many of your tweets those with a talent for mildly clouding the mind and obscuring $SGMO s value. Encouragingly that particular haze now seems likely to clear rather suddenly. $FOLD #Fabry"
X Link 2025-12-21T13:31Z [---] followers, [---] engagements

"@BiotechAnalysst Will @AstellasUS give some @SangamoTx partnership updates/outlook here $SGMO $ALPMY https://alliancerm.org/events/sotibriefing/ https://alliancerm.org/events/sotibriefing/"
X Link 2026-01-06T15:27Z [---] followers, [----] engagements

"@BiotechAnalysst Link to this Japanese $SGMO #Fabry #Patent https://patents.google.com/patent/JP2025142225A/en https://patents.google.com/patent/JP2025142225A/en"
X Link 2026-01-12T15:22Z [----] followers, [----] engagements

"@TheCryptoMaze @809trader I would give $SGMO a few more weeks (not days) - roughly another four - to provide further #Fabry updates. At this stage Im looking more closely at the Fabry World Symposium than #JPM2026 on that front. But I always could be wrong 😞 https://worldsymposia.org/worldsymposia-lysosomal-disease-updates/ https://worldsymposia.org/worldsymposia-lysosomal-disease-updates/"
X Link 2026-01-13T15:34Z [----] followers, [---] engagements

"Thrilled to see our work featured at @BPoD_s Not just the image - also the tissue-clearing technique behind it: #ADAPT3D Big thanks to colleagues & collaborators at @washumedicine @washu_pathology @WashU Kit also available via @LeincoSTL https://www.researchsquare.com/article/rs-6109657/v1 A Clear Look: New approach to tissue clearing for light-sheet microscopy called ADAPT-3D preserves architecture for 3D imaging 📷 Daniel D. Lee & Kevin A. Telfer et al @washumedicine in @SciReports ➡ https://t.co/tXxGB42M6y with @AntDLewis https://t.co/YE5gah8pzX"
X Link 2026-01-13T16:46Z [----] followers, [---] engagements

"@mehtamanal @sandymacrae23 Thoughts/Speculation on @SangamoTx #Fabry deal/partnering: My hunch is that a #VC partner is more likely than BP partner. If anything $SGMO is built for #BP partnering its #CNS #Capsid #MINT that still need clinical execution and $$$ https://www.linkedin.com/posts/zinselmeyer_healtheconomics-genetherapy-raredisease-activity-7415118462609448960-nPiGutm_source=social_share_send&utm_medium=member_desktop_web&rcm=ACoAAAJADAkBzV4TwdZc8RXlwfUmwRW2beOtoqY"
X Link 2026-01-15T15:53Z [----] followers, [----] engagements

"@Gr8unionsJohn @809trader @BehaviorFin @yusufhameed @Franca_ole @kaysaaa81 @BiotechAnalysst @sandymacrae23 Cash inflow to $SGMO should lead to higher Stock Price"
X Link 2026-01-20T20:02Z [----] followers, [---] engagements

"@8vc nails it: rare diseases arent a science problemtheyre an incentives problem. Thats why late-stage cures get mispriced. My own example (not in the article): $SGMO s ST-920 (#Fabry) is already in rolling #BLA. Stop pricing cures like noise https://www.8vc.com/resources/the-crisis-and-opportunity-in-rare-diseases https://www.8vc.com/resources/the-crisis-and-opportunity-in-rare-diseases"
X Link 2026-01-26T20:34Z [----] followers, [----] engagements

"@schieritz One way or another the Eva Anna Paula Braun scenario isnt entirely out of the question "
X Link 2026-01-26T21:32Z [----] followers, [---] engagements

"@809trader Bonus Not quite: Its standard RSU vesting with automatic share withholding to cover mandatory taxes under the plan - hardly a management windfall and not an open-market sale. $SGMO"
X Link 2026-01-26T22:16Z [----] followers, [---] engagements

"@809trader @Valueinvestor41 Shorts know the cash runway and the ATC (at-the-market) mechanics - that part is easy. What they dont seem to grasp is the value of @SangamoTx projects and IP. And the reverse-split drama [--] shares at $0.40 traded in [--] share at $4 - what's the difference; optics change $SGMO"
X Link 2026-01-26T23:42Z [----] followers, [---] engagements

"@BiotechAnalysst in opposite to many Neurodegenerative Diseases where a clinical trial readout could take several years - $SGMOS pain program when coming to clinical trials Success could be easy evaluated a few weeks after dosing"
X Link 2023-05-22T16:43Z [----] followers, [---] engagements

"@DHogweed @RNAiAnalyst @sandymacrae23 Intresting as the mentioned Analyst Maury Raycroft @Jefferies maintained his PT for $SGMO between $8 to $25$ after that meeting "
X Link 2024-07-01T14:30Z [----] followers, [----] engagements

"@Gr8unionsJohn Maybe @adamfeuerstein knows something or someone who went to the $SGMO @SangamoTx at H.C. Wainwright & Co. LLC"
X Link 2025-01-13T16:26Z [----] followers, [----] engagements

"@Franca_ole He's not that optimistic anymorehis current $SGMO target is $7.50 driven by the $PFE #HemA rejection and the uncertain political and regulatory environment"
X Link 2025-04-10T14:34Z [----] followers, [---] engagements

"@Franca_ole Very interesting to compare this @SangamoTx patent with @Roche 's new $2B brain-shuttle deal with @ManifoldBio. Both aim to shuttle therapeutics like proteins and antibodies into the CNS but with very different modalities. $SGMO $RHHBY https://www.fiercebiotech.com/biotech/roche-signs-2b-pact-pilot-manifold-bios-shuttles-brain https://www.fiercebiotech.com/biotech/roche-signs-2b-pact-pilot-manifold-bios-shuttles-brain"
X Link 2025-12-04T13:22Z [----] followers, [---] engagements

"@BiotechAnalysst @Official_Cantor @SangamoTx @cantorfitzgerld Also worth highlighting: $SGMO s #BBB-crossing capsids are already partner-validated with deals involving $RHHBY (@Roche) $LLY (@LillyPad) and $AZN (@AstraZeneca / Alexion). This isnt theoretical platform hype: Its CNS delivery tech big pharma is already paying for"
X Link 2025-12-13T15:52Z [----] followers, [----] engagements

"@TheCryptoMaze https://newsroom.astellas.com/2026-01-07-astellas-to-present-at-44th-annual-j-p-morgan-healthcare-conference https://newsroom.astellas.com/2026-01-07-astellas-to-present-at-44th-annual-j-p-morgan-healthcare-conference"
X Link 2026-01-12T15:31Z [----] followers, [----] engagements

"@karenlynchkaren @Bobischoff @Puettmann_Bonn: The true conservative is a person of moderation and stability - sceptical and detached - whose individualism serves the common good not the pack. He values tradition as democracy with the dead (G. K. Chesterton) and humbly acknowledges human fallibility"
X Link 2026-01-28T20:27Z [----] followers, [--] engagements

"@yusufhameed @RNAiAnalyst @whitecollar86 @jimcramer @BiotechAnalysst @p72vc @GeneInvesting @CathieDWood @ARKInvest I am ok with this kind of normal $SGMO"
X Link 2026-01-29T14:35Z [----] followers, [---] engagements

"@mehtamanal Thats a fantastic paper by @EdwinNNeumann / @JswLab / @WhiteheadInst using @SangamoTx #ZiFi Ive highlighted it several times But its from [----] so why would a [----] paper be responsible for todays move in $SGMO Whats the actual catalyst here 👀 https://x.com/ZinselmeyerB/status/1808855528006664518 @BowTiedBiotech It's a beautiful editorial highlighting the @EdwinNNeumann paper by @JswLab @WhiteheadInst using @SangamoTx $sgmo #zfp licensed to @chromamedicine https://t.co/DbW0ShlSBf #epigenetic #genetherapy #zfps #zfn #genomicmedicine"
X Link 2026-01-29T17:57Z [----] followers, [---] engagements

"Revisiting @SangamoTx last years ST-920 #Fabry gene therapy material - a deliberate warm-up ahead of new updates at [----] WorldSymposium next week. Feels increasingly launch-adjacent. $SGMO https://youtu.be/2AsXPEnkBOcsi=LnQJzBFLRap4ALnC https://youtu.be/2AsXPEnkBOcsi=LnQJzBFLRap4ALnC"
X Link 2026-01-30T08:42Z [----] followers, [----] engagements

"@Corona_N_Lyme With starting on Monday and a real possibility of news flow over the weekend do you happen to have an estimate of the current short interest in $SGMO - roughly how many shares are short at the moment An educated guess is perfectly fine as well . https://worldsymposia.org/ https://worldsymposia.org/"
X Link 2026-01-30T20:46Z [----] followers, [----] engagements

"@DakotaSpin $SGMO 's gains last week are more than a purely technical case. While the chart structure is improving the fundamentals also support a materially higher valuation: https://x.com/i/status/2017156525274333689 Revisiting @SangamoTx last years ST-920 #Fabry gene therapy material - a deliberate warm-up ahead of new updates at [----] WorldSymposium next week. Feels increasingly launch-adjacent. $SGMO https://t.co/l9v6oTqkcB https://x.com/i/status/2017156525274333689 Revisiting @SangamoTx last years ST-920 #Fabry gene therapy material - a deliberate warm-up ahead of new updates at 2026"
X Link 2026-02-01T18:17Z [----] followers, [----] engagements

"@yusufhameed @SangamoTx $SGMO https://x.com/i/status/2018327615967215747 $SGMOEmbargo Policy applies to all [----] platform AND poster [----] posters and ePosters will be available beginning on #Tuesday February [--] [----] at05:00PST #embargo #liftsfor all oraland posterpresentationsat 05:00 PSTwhen posters and ePosters arereleasedto theaudience https://t.co/rRYpobTB4Z https://x.com/i/status/2018327615967215747 $SGMOEmbargo Policy applies to all [----] platform AND poster [----] posters and ePosters will be available beginning on #Tuesday February [--] [----] at05:00PST #embargo #liftsfor all oraland"
X Link 2026-02-02T14:24Z [----] followers, [---] engagements

"@Soeren_Berlin @HarryStebbings @easyJet"
X Link 2026-02-02T19:22Z [----] followers, [---] engagements

"Does this imply that $SGMO knows who this SINGLE investor is and has discussed the investors intentions directly ". @SangamoTx agreed to reduce the exercise price on outstanding warrants to purchase [--------] shares of common stock ." https://investor.sangamo.com/news-releases/news-release-details/sangamo-therapeutics-announces-pricing-250-million-underwrittenhttps://investor.sangamo.com/news-releases/news-release-details/sangamo-therapeutics-announces-pricing-250-million-underwritten"
X Link 2026-02-03T19:47Z [----] followers, [----] engagements

"@Corona_N_Lyme @SangamoTx Agree 100% on $SGMO @SangamoTx #1 problem is communication No more vagueness: [-----] day milestones. Cash runway/burn. Financing plan. Clear strategy. Silence creates a vacuum rumors + volatility. Mgmt: put the plan on the record https://www.linkedin.com/posts/zinselmeyer_worldsymposium2026-fabry-epigenetic-activity-7424866825307484160-lBww https://www.linkedin.com/posts/zinselmeyer_worldsymposium2026-fabry-epigenetic-activity-7424866825307484160-lBww"
X Link 2026-02-04T18:17Z [----] followers, [----] engagements

"@btcbabey @BiotechAnalysst I wouldnt rule out a #buyout / #BO for $SGMO. That said it does look as though a lead investor is stepping in and the markets rumour mill has -unsurprisingly - settled on Armistice Capital LLC. Speculation for now of course but its one to watch: https://x.com/ZinselmeyerB/status/2019113198931382625s=20 @Corona_N_Lyme @SangamoTx Agree 100% on $SGMO @SangamoTx #1 problem is communication No more vagueness: [-----] day milestones. Cash runway/burn. Financing plan. Clear strategy. Silence creates a vacuum rumors + volatility. Mgmt: put the plan on the record"
X Link 2026-02-06T17:00Z [----] followers, [---] engagements

"@TraderNorway More background on $SGMO #Fabry GT Isaralgagene civaparvovec (ST-920). For traders (most arent intrested in details): The $1 bid issue is extendable so a reverse split isnt a given. Runway looks sufficient to reach the BLA filing: https://x.com/ZinselmeyerB/status/2019120198977012168s=20 @JanvDes @kikiruncha NO #Fabry $SGMO @SangamoTx : Commercialise it in house. After approval the cost base is much lower than the market thinks - no need for a huge commercial footprint. https://t.co/svCOM0RJz5 https://t.co/PSA9qZYOiE https://x.com/ZinselmeyerB/status/2019120198977012168s=20"
X Link 2026-02-06T20:57Z [----] followers, [---] engagements

"@Soeren_Berlin @Analysethat @BiotechAnalysst Indeed - most institutional investors dont buy penny stocks or companies with such a low market cap especially once theyve fallen out of the major indices"
X Link 2025-11-05T16:57Z [----] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing